Why overall survival should not be the sole valid primary endpoint of phase 3 ovarian cancer chemotherapy trials
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynecology,Oncology
Reference11 articles.
1. Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: An intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG;Pfisterer;J. Clin. Oncol.,2006
2. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer;McGuire;N. Engl. J. Med.,1996
3. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three year results;Piccart;J. Natl. Cancer Inst.,2000
4. Intraperitoneal cisplatin and paclitaxel in ovarian cancer;Armstrong;N. Engl. J. Med.,2006
5. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial;Parmar;Lancet,2003
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Survival and overall treatment time after postoperative radio(chemo)therapy in patients with head and neck cancer;Head & Neck;2016-02-13
2. A Systematic Model Specification Procedure for an Illness-Death Model without Recovery;PLOS ONE;2015-04-13
3. Emerging treatment strategies in recurrent platinum-sensitive ovarian cancer: Focus on trabectedin;Cancer Treatment Reviews;2014-04
4. Patient relevant endpoints in oncology: current issues in the context of early benefit assessment in Germany;Health Economics Review;2014-01-24
5. CYP2D6 Genotype and Tamoxifen Response for Breast Cancer: A Systematic Review and Meta-Analysis;PLoS ONE;2013-10-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3